tanshinone has been researched along with fluorouracil in 2 studies
| Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) | Studies (fluorouracil) | Trials (fluorouracil) | Recent Studies (post-2010) (fluorouracil) |
|---|---|---|---|---|---|
| 1,445 | 10 | 1,033 | 45,562 | 9,307 | 14,663 |
| Protein | Taxonomy | tanshinone (IC50) | fluorouracil (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.32 | |
| Thymidylate synthase | Mus musculus (house mouse) | 1.58 | |
| Aromatase | Homo sapiens (human) | 0.63 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, DR; Chen, YL; Cheng, CY; Chien, SY; Kuo, SJ; Su, CC | 1 |
| Cao, FL; Li, NY; Li, YP; Liu, YQ; Lv, CL; Xu, M | 1 |
2 other study(ies) available for tanshinone and fluorouracil
| Article | Year |
|---|---|
Tanshinone IIA inhibits human hepatocellular carcinoma J5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo.
Topics: Abietanes; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mice; Mice, Nude; Platelet Endothelial Cell Adhesion Molecule-1; Transplantation, Heterologous | 2012 |
Tanshinone IIA reverses the malignant phenotype of SGC7901 gastric cancer cells.
Topics: Abietanes; Analysis of Variance; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Fluorouracil; G1 Phase Cell Cycle Checkpoints; Humans; Phenotype; S Phase Cell Cycle Checkpoints; Stomach Neoplasms; Time Factors | 2013 |